Last 12 months
Inside the activity.
1 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC |
Cordani DavidDirector · Chairman & CEO
|
GrantCommon Stock, $.01 Par Value | 35,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003707 · doc4.xml · nonDerivative · entry 1 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 382,656 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC |
BRAILER DAVID JEVP & Chief Health Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 1,099 | $333.36 | $366,362.64 |
DisclosureSEC source: 0001225208-24-003706 · doc4.xml · nonDerivative · entry 3 BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,332 F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC |
BRAILER DAVID JEVP & Chief Health Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 412 | $333.36 | $137,344.32 |
DisclosureSEC source: 0001225208-24-003706 · doc4.xml · nonDerivative · entry 2 BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,431 F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC |
BRAILER DAVID JEVP & Chief Health Officer
|
GrantCommon Stock, $.01 Par Value | 2,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003706 · doc4.xml · nonDerivative · entry 1 BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,843 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC |
Evanko Brian CSee Remarks
|
Tax withholdingCommon Stock, $.01 Par Value | 3,860 | $333.36 | $1,286,769.60 |
DisclosureSEC source: 0001225208-24-003709 · doc4.xml · nonDerivative · entry 3 Evanko Brian C · CIK 0001722909 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,923 F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC |
Evanko Brian CSee Remarks
|
Tax withholdingCommon Stock, $.01 Par Value | 1,575 | $333.36 | $525,042.00 |
DisclosureSEC source: 0001225208-24-003709 · doc4.xml · nonDerivative · entry 2 Evanko Brian C · CIK 0001722909 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,783 F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC |
Evanko Brian CSee Remarks
|
GrantCommon Stock, $.01 Par Value | 8,329 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003709 · doc4.xml · nonDerivative · entry 1 Evanko Brian C · CIK 0001722909 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,358 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC |
Triplett Michael WSpecial Advisor
|
Tax withholdingCommon Stock, $.01 Par Value | 2,492 | $333.36 | $830,733.12 |
DisclosureSEC source: 0001225208-24-003705 · doc4.xml · nonDerivative · entry 3 Triplett Michael W · CIK 0001698840 · Special Advisor 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,405 F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC |
Triplett Michael WSpecial Advisor
|
Tax withholdingCommon Stock, $.01 Par Value | 749 | $333.36 | $249,686.64 |
DisclosureSEC source: 0001225208-24-003705 · doc4.xml · nonDerivative · entry 2 Triplett Michael W · CIK 0001698840 · Special Advisor 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,897 F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC |
Triplett Michael WSpecial Advisor
|
GrantCommon Stock, $.01 Par Value | 5,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003705 · doc4.xml · nonDerivative · entry 1 Triplett Michael W · CIK 0001698840 · Special Advisor 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,646 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC |
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 532 | $333.36 | $177,347.52 |
DisclosureSEC source: 0001225208-24-003704 · doc4.xml · nonDerivative · entry 3 Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,586.324 F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC |
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
|
Tax withholdingCommon Stock, $.01 Par Value | 224 | $333.36 | $74,672.64 |
DisclosureSEC source: 0001225208-24-003704 · doc4.xml · nonDerivative · entry 2 Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,118.324 F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC |
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
|
GrantCommon Stock, $.01 Par Value | 1,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003704 · doc4.xml · nonDerivative · entry 1 Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,342.324 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 00:44 UTC |
WISEMAN ERIC CDirector
|
GrantPhantom Stock Units · Derivative | 117.5106 | $336.14 | $39,500.01 |
DisclosureSEC source: 0001225208-24-003412 · doc4.xml · derivative · entry 1 WISEMAN ERIC C · CIK 0001237851 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,763.9471 Underlying: Common Stock, $.01 Par Value · 117.5106 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F2 · balance_after: Includes 31.5111 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan. Read SEC document |
| February 29, 2024 Filed Mar 2, 2024 00:44 UTC |
Kurian GeorgeDirector
|
GrantPhantom Stock Units · Derivative | 89.2485 | $336.14 | $29,999.99 |
DisclosureSEC source: 0001225208-24-003411 · doc4.xml · derivative · entry 1 Kurian George · CIK 0001586813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 991.2836 Underlying: Common Stock, $.01 Par Value · 89.2485 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash. F2 · balance_after: Includes 3.7173 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
Triplett Michael WSpecial Advisor
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,226 | $0.00 Strike: $336.48 | $0.00 |
DisclosureSEC source: 0001225208-24-003419 · doc4.xml · derivative · entry 3 Triplett Michael W · CIK 0001698840 · Special Advisor 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,226 Underlying: Common Stock, $.01 Par Value · 6,226 shares Expires 2034-02-28 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
Triplett Michael WSpecial Advisor
|
GrantCommon Stock, $.01 Par Value | 1,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003419 · doc4.xml · nonDerivative · entry 1 Triplett Michael W · CIK 0001698840 · Special Advisor 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,944 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
Palmer Eric PSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,677 | $0.00 Strike: $336.48 | $0.00 |
DisclosureSEC source: 0001225208-24-003418 · doc4.xml · derivative · entry 5 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,677 Underlying: Common Stock, $.01 Par Value · 18,677 shares Expires 2034-02-28 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
Palmer Eric PSee Remarks
|
GrantCommon Stock, $.01 Par Value | 5,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003418 · doc4.xml · nonDerivative · entry 1 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,169 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
Jones Nicole SSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,677 | $0.00 Strike: $336.48 | $0.00 |
DisclosureSEC source: 0001225208-24-003417 · doc4.xml · derivative · entry 3 Jones Nicole S · CIK 0001492663 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,677 Underlying: Common Stock, $.01 Par Value · 9,677 shares Expires 2034-02-28 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
Jones Nicole SSee Remarks
|
GrantCommon Stock, $.01 Par Value | 2,657 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003417 · doc4.xml · nonDerivative · entry 1 Jones Nicole S · CIK 0001492663 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,726 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
Evanko Brian CSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,677 | $0.00 Strike: $336.48 | $0.00 |
DisclosureSEC source: 0001225208-24-003416 · doc4.xml · derivative · entry 3 Evanko Brian C · CIK 0001722909 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,677 Underlying: Common Stock, $.01 Par Value · 18,677 shares Expires 2034-02-28 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
Evanko Brian CSee Remarks
|
GrantCommon Stock, $.01 Par Value | 5,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003416 · doc4.xml · nonDerivative · entry 1 Evanko Brian C · CIK 0001722909 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,029 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
Cordani DavidDirector · Chairman & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 36,162 | $0.00 Strike: $336.48 | $0.00 |
DisclosureSEC source: 0001225208-24-003415 · doc4.xml · derivative · entry 5 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,162 Underlying: Common Stock, $.01 Par Value · 36,162 shares Expires 2034-02-28 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
Cordani DavidDirector · Chairman & CEO
|
GrantCommon Stock, $.01 Par Value | 9,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003415 · doc4.xml · nonDerivative · entry 1 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,710 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
BRAILER DAVID JEVP & Chief Health Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 11,369 | $0.00 Strike: $336.48 | $0.00 |
DisclosureSEC source: 0001225208-24-003414 · doc4.xml · derivative · entry 2 BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,369 Underlying: Common Stock, $.01 Par Value · 11,369 shares Expires 2034-02-28 F2 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
BRAILER DAVID JEVP & Chief Health Officer
|
GrantCommon Stock, $.01 Par Value | 3,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003414 · doc4.xml · nonDerivative · entry 1 BRAILER DAVID J · CIK 0001222879 · EVP & Chief Health Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,063 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
Eder Noelle KSee Remarks
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,677 | $0.00 Strike: $336.48 | $0.00 |
DisclosureSEC source: 0001225208-24-003413 · doc4.xml · derivative · entry 3 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,677 Underlying: Common Stock, $.01 Par Value · 9,677 shares Expires 2034-02-28 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC |
Eder Noelle KSee Remarks
|
GrantCommon Stock, $.01 Par Value | 2,657 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003413 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,581 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 27, 2024 Filed Feb 27, 2024 22:48 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $139.22 | $0.00 |
DisclosureSEC source: 0001225208-24-003131 · doc4.xml · derivative · entry 14 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,429 Underlying: Common Stock, $.01 Par Value · 2,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. F7 · derivative.exercise_date: This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| February 27, 2024 Filed Feb 27, 2024 22:48 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 2,000 | $345.04 | $690,075.00 |
DisclosureSEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 8 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 336,783 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. F5 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $345 to $345.095 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 27, 2024 Filed Feb 27, 2024 22:48 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionCommon Stock, $.01 Par Value | 2,000 | $139.22 | $278,440.00 |
DisclosureSEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 7 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 338,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 22:48 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,453 | $0.00 Strike: $139.22 | $0.00 |
DisclosureSEC source: 0001225208-24-003131 · doc4.xml · derivative · entry 13 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,429 Underlying: Common Stock, $.01 Par Value · 10,453 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. F7 · derivative.exercise_date: This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 22:48 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 6,829 | $345.34 | $2,358,298.18 |
DisclosureSEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 6 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 336,783 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. F4 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $345.00 to $345.98 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 22:48 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 3,524 | $346.38 | $1,220,640.65 |
DisclosureSEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 5 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 343,612 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. F3 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $346.02 to $347.01 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 22:48 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 100 | $347.14 | $34,713.50 |
DisclosureSEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 4 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 347,136 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 22:48 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionCommon Stock, $.01 Par Value | 10,453 | $139.22 | $1,455,266.66 |
DisclosureSEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 3 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 347,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:48 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,319 | $0.00 Strike: $139.22 | $0.00 |
DisclosureSEC source: 0001225208-24-003131 · doc4.xml · derivative · entry 12 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,882 Underlying: Common Stock, $.01 Par Value · 6,319 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. F7 · derivative.exercise_date: This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:48 UTC |
Cordani DavidDirector · Chairman & CEO
|
SaleCommon Stock, $.01 Par Value | 6,319 | $345.24 | $2,181,592.41 |
DisclosureSEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 2 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 336,783 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. F2 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $345.00 to $345.59 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 22:48 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionCommon Stock, $.01 Par Value | 6,319 | $139.22 | $879,731.18 |
DisclosureSEC source: 0001225208-24-003131 · doc4.xml · nonDerivative · entry 1 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 343,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 22:57 UTC |
DeLaney William J IIIDirector
|
GiftCommon Stock, $.01 Par Value | 3,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002542 · doc4.xml · nonDerivative · entry 1 DeLaney William J III · CIK 0001384151 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 F1 · balance_after: Total holdings were increased by one share of common stock due to an error on the Form 4 report that was filed on November 10, 2022. Read SEC document |
| February 15, 2024 Filed Feb 15, 2024 22:30 UTC |
Palmer Eric PSee Remarks
|
GiftCommon Stock, $.01 Par Value | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002196 · doc4.xml · nonDerivative · entry 6 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,437 Read SEC document |
| February 15, 2024 Filed Feb 15, 2024 22:30 UTC |
Palmer Eric PSee Remarks
|
GiftCommon Stock, $.01 Par Value | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002196 · doc4.xml · nonDerivative · entry 5 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,042 Read SEC document |
| February 15, 2024 Filed Feb 15, 2024 22:30 UTC |
Palmer Eric PSee Remarks
|
GiftCommon Stock, $.01 Par Value | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002196 · doc4.xml · nonDerivative · entry 4 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,354 Read SEC document |
| February 14, 2024 Filed Feb 15, 2024 22:30 UTC |
Palmer Eric PSee Remarks
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 905 | $0.00 Strike: $149.14 | $0.00 |
DisclosureSEC source: 0001225208-24-002196 · doc4.xml · derivative · entry 10 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 905 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Read SEC document |
| February 14, 2024 Filed Feb 15, 2024 22:30 UTC |
Palmer Eric PSee Remarks
|
Exercise / conversionCommon Stock, $.01 Par Value | 905 | $149.14 | $134,967.18 |
DisclosureSEC source: 0001225208-24-002196 · doc4.xml · nonDerivative · entry 3 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Read SEC document |
| February 13, 2024 Filed Feb 13, 2024 22:27 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,462 | $0.00 Strike: $139.22 | $0.00 |
DisclosureSEC source: 0001225208-24-001958 · doc4.xml · derivative · entry 13 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,201 Underlying: Common Stock, $.01 Par Value · 7,462 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. F8 · derivative.exercise_date: This option was granted on March 1, 2016. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. Read SEC document |
| February 13, 2024 Filed Feb 13, 2024 22:27 UTC |
Cordani DavidDirector · Chairman & CEO
|
Exercise / conversionCommon Stock, $.01 Par Value | 7,462 | $139.22 | $1,038,859.64 |
DisclosureSEC source: 0001225208-24-001958 · doc4.xml · nonDerivative · entry 7 Cordani David · CIK 0001318751 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 336,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2023. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:30 UTC |
Palmer Eric PSee Remarks
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,168 | $0.00 Strike: $149.14 | $0.00 |
DisclosureSEC source: 0001225208-24-002196 · doc4.xml · derivative · entry 9 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 905 Underlying: Common Stock, $.01 Par Value · 5,168 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:30 UTC |
Palmer Eric PSee Remarks
|
SaleCommon Stock, $.01 Par Value | 6,083 | $340.00 | $2,068,220.00 |
DisclosureSEC source: 0001225208-24-002196 · doc4.xml · nonDerivative · entry 2 Palmer Eric P · CIK 0001710190 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,649 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.